Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional Selectivity of Allosteric Interactions within G Protein–Coupled Receptor Oligomers: The Dopamine D1-D3 Receptor Heterotetramer
Xavier Guitart, Gemma Navarro, Estefanía Moreno, et al.
Molecular Pharmacology (2014) Vol. 86, Iss. 4, pp. 417-429
Open Access | Times Cited: 116

Showing 76-100 of 116 citing articles:

Loss of dopamine D1 receptors and diminished D1/5 receptor-mediated ERK phosphorylation in the periaqueductal gray after spinal cord lesion
Pamela J. Voulalas, Yadong Ji, Jiang Li, et al.
Neuroscience (2016) Vol. 343, pp. 94-105
Open Access | Times Cited: 16
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons
Carlo Matera, Federica Bono, Silvia Pelucchi, et al.
Biochemical Pharmacology (2019) Vol. 163, pp. 154-168
Open Access | Times Cited: 16
Revisiting the Functional Role of Dopamine D4 Receptor Gene Polymorphisms: Heteromerization-Dependent Gain of Function of the D4.7 Receptor Variant
Marta Sánchez‐Soto, Hideaki Yano, Ning-Sheng Cai, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 7, pp. 4778-4785
Open Access | Times Cited: 16
Dopaminergic denervation switches dopamine D3 receptor signaling and disrupts its Ca2+ dependent modulation by CaMKII and calmodulin in striatonigral projections of the rat
Arturo Ávalos‐Fuentes, Sacnité Albarrán‐Bravo, Santiago Loya‐López, et al.
Neurobiology of Disease (2014) Vol. 74, pp. 336-346
Closed Access | Times Cited: 15
Exploring functional consequences of GPCR oligomerization requires a different lens
Kyla Bourque, Jace Jones-Tabah, Dominic Devost, et al.
Progress in molecular biology and translational science (2019), pp. 181-211
Closed Access | Times Cited: 14
BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia
Simona Scheggi, Francesca Rossi, Sara Corsi, et al.
Journal of Parkinson s Disease (2020) Vol. 10, Iss. 4, pp. 1503-1514
Closed Access | Times Cited: 13
Overcoming the Challenges of Detecting GPCR Oligomerization in the Brain
Víctor Fernández‐Dueñas, Jordi Bonaventura, Ester Aso, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 6, pp. 1035-1045
Open Access | Times Cited: 12
Morphine responsiveness to thermal pain stimuli is aging-associated and mediated by dopamine D1 and D3 receptor interactions
Sophia Samir, Alexander P. Yllanes, Perrine Lallemand, et al.
Neuroscience (2017) Vol. 349, pp. 87-97
Open Access | Times Cited: 13
Presynaptic control of [3H]-glutamate release by dopamine receptor subtypes in the rat substantia nigra. Central role of D1 and D3 receptors
Laura Jesús Briones-Lizardi, Hernán Cortés, José Arturo Ávalos‐Fuentes, et al.
Neuroscience (2019) Vol. 406, pp. 563-579
Closed Access | Times Cited: 13
The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome
Antoni Cortés, Verònica Casadó-Anguera, Estefanía Moreno, et al.
Advances in pharmacology (2019), pp. 37-78
Closed Access | Times Cited: 11
Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
Kathryn Lanza, Christopher Bishop
Biomedicines (2021) Vol. 9, Iss. 3, pp. 314-314
Open Access | Times Cited: 10
Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs
Verònica Casadó-Anguera, Antoni Cortés, Vicent Casadó, et al.
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 12, pp. 1297-1312
Closed Access | Times Cited: 10
D3 and D1 receptors: The Yin and Yang in the treatment of restless legs syndrome with dopaminergics
Stefan Clemens, Imad Ghorayeb
Advances in pharmacology (2019), pp. 79-100
Closed Access | Times Cited: 9
Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat
Kathryn Lanza, Katherine Chemakin, Sarah Lefkowitz, et al.
Psychopharmacology (2019) Vol. 237, Iss. 1, pp. 155-165
Closed Access | Times Cited: 9
Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects
Sacnité Albarrán‐Bravo, José Arturo Ávalos‐Fuentes, Hernán Cortés, et al.
Biomolecules (2019) Vol. 9, Iss. 9, pp. 431-431
Open Access | Times Cited: 7
Extreme Vetting of Dopamine Receptor Oligomerization
Wesley B. Asher, Signe Mathiasen, Michael D. Holsey, et al.
Springer eBooks (2017), pp. 99-127
Closed Access | Times Cited: 6
Heteromerization between α2A adrenoceptors and different polymorphic variants of the dopamine D4 receptor determines pharmacological and functional differences. Implications for impulsive-control disorders
Verònica Casadó-Anguera, Estefanía Moreno, Marta Sánchez‐Soto, et al.
Pharmacological Research (2021) Vol. 170, pp. 105745-105745
Open Access | Times Cited: 6
G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2
Federica Bono, Zaira Tomasoni, Veronica Mutti, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 473-473
Open Access | Times Cited: 2
Significant Functional Differences Between Dopamine D4 Receptor Polymorphic Variants Upon Heteromerization with α1A Adrenoreceptors
Patricia Homar-Ruano, Ning-Sheng Cai, Verònica Casadó-Anguera, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6566-6583
Open Access | Times Cited: 2
Hormones and Neuropeptide Receptor Heteromers in the Ventral Tegmental Area. Targets for the Treatment of Loss of Control of Food Intake and Substance Use Disorders
Sergi Ferré
Current Treatment Options in Psychiatry (2017) Vol. 4, Iss. 2, pp. 167-183
Open Access | Times Cited: 5
Recent Advances in Dopamine D3 Receptor Heterodimers: Focus on Dopamine D3 and D1 Receptor–Receptor Interaction and Striatal Function
Federica Bono, Veronica Mutti, Zaira Tomasoni, et al.
Current topics in behavioral neurosciences (2022), pp. 47-72
Closed Access | Times Cited: 4
Exploration in the Mechanism of Zhisou San for the Treatment of Cough Variant Asthma Based on Network Pharmacology
De-hai Guo, Jin-Ping Hao, Xingjie Li, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 4
Loss of Function in Dopamine D3 Receptor Attenuates Left Ventricular Cardiac Fibroblast Migration and Proliferation in vitro
Andrew Kisling, Shannon E Byrne, Rohan Umesh Parekh, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 5
The Use of Spatial Intensity Distribution Analysis to Examine G Protein-Coupled Receptor Oligomerization
Richard J. Ward, Sara Marsango, John D. Pediani, et al.
Springer eBooks (2017), pp. 15-38
Closed Access | Times Cited: 4
Coexistence of D3R typical and atypical signaling in striatonigral neurons during dopaminergic denervation. Correlation with D3nf expression changes
Baruc Campos, Arturo Ávalos‐Fuentes, Celia Piña Leyva, et al.
Synapse (2020) Vol. 74, Iss. 8
Closed Access | Times Cited: 4

Scroll to top